An analysis of studies involving the drug memantine finds a lack of evidence for benefit when the drug is used to treat patients with mild Alzheimer disease and mild cognitive impairment, according to ...

This release is available in German. There is no scientific proof that patients with moderate or severe Alzheimer's disease benefit from drugs containing the agent memantine. This is the conclusion in ...

There is no scientific proof that patients with moderate or severe Alzheimer's disease benefit from drugs containing the agent memantine, according to a new report. There is no scientific proof that ...

MIAMI — A drug that for years has been approved to treat moderate to severe Alzheimer's disease may have a role in improving the cognitive deficits associated with bipolar disorder. In a randomized, ...

Elevated pregenual anterior cingulate cortex levels were associated with a favorable treatment response. HealthDay News — Memantine improves social impairments in youth with autism spectrum disorder ...

NEW YORK, Feb. 5 -- Forest Laboratories, Inc. (NYSE: FRX - News) today announced preliminary results of a Phase III study of memantine HCl (currently marketed as Namenda®, a twice-daily immediate- ...

“A balanced and skillful approach to life, taking care to avoid extremes, becomes a very important factor in conducting one's everyday existence. It is important in all aspects of life.” —The Dalai ...